We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBPH icon
2051
Theravance Biopharma
TBPH
$877M
$35K ﹤0.01%
1,798
+732
+69% +$14.8K
TXNM
2052
TXNM Energy Inc
TXNM
$5.94B
$35K ﹤0.01%
666
-2,954
-82% -$149K
PRSU
2053
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
$35K ﹤0.01%
+522
New +$35.1K
MCBC
2054
DELISTED
Macatawa Bank Corp
MCBC
$35K ﹤0.01%
+3,375
New +$34.3K
CBD
2055
DELISTED
Companhia Brasileira de Distribuicao
CBD
$35K ﹤0.01%
1,826
+1,786
+4,465% +$39.9K
USWS
2056
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$35K ﹤0.01%
761
+741
+3,705% +$48.7K
PMBC
2057
DELISTED
Pacific Mercantile Bancorp
PMBC
$35K ﹤0.01%
4,624
+3,037
+191% +$23.9K
GHDX
2058
DELISTED
Genomic Health, Inc.
GHDX
$35K ﹤0.01%
518
+213
+70% +$14.6K
ORBC
2059
DELISTED
ORBCOMM, Inc.
ORBC
$35K ﹤0.01%
7,220
+6,578
+1,025% +$39.3K
AVNS
2060
DELISTED
Avanos Medical
AVNS
$34K ﹤0.01%
897
-2,377
-73% -$90.7K
BFAM icon
2061
Bright Horizons
BFAM
$3.86B
$34K ﹤0.01%
225
-7,058
-97% -$1.1M
BUSE icon
2062
First Busey Corp
BUSE
$2.56B
$34K ﹤0.01%
1,333
-308
-19% -$7.89K
CARG icon
2063
CarGurus
CARG
$3.47B
$34K ﹤0.01%
1,114
+753
+209% +$25.7K
CHDN icon
2064
Churchill Downs
CHDN
$6.12B
$34K ﹤0.01%
558
-524
-48% -$31.6K
DCI icon
2065
Donaldson
DCI
$11.4B
$34K ﹤0.01%
649
-12,224
-95% -$605K
GPI icon
2066
Group 1 Automotive
GPI
$3.18B
$34K ﹤0.01%
+366
New +$30.1K
HE icon
2067
Hawaiian Electric Industries
HE
$2.14B
$34K ﹤0.01%
761
-211
-22% -$9.38K
KPTI icon
2068
Karyopharm Therapeutics
KPTI
$48M
$34K ﹤0.01%
232
+196
+544% +$26.6K
LILAK icon
2069
Liberty Latin America Class C
LILAK
$1.64B
$34K ﹤0.01%
+2,306
New +$33.2K
MKSI icon
2070
MKS Inc
MKSI
$20.6B
$34K ﹤0.01%
366
-3,335
-90% -$275K
PEN icon
2071
Penumbra
PEN
$12.8B
$34K ﹤0.01%
251
-804
-76% -$124K
PNNT
2072
Pennant Park Investment Corp
PNNT
$241M
$34K ﹤0.01%
5,422
+4,541
+515% +$29K
POOL icon
2073
Pool Corp
POOL
$7.5B
$34K ﹤0.01%
171
-607
-78% -$117K
SPSC icon
2074
SPS Commerce
SPSC
$2.64B
$34K ﹤0.01%
724
+648
+853% +$32.9K
STRA icon
2075
Strategic Education
STRA
$1.92B
$34K ﹤0.01%
252
-470
-65% -$80.2K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.